Natixis Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,460
| Closed | -$251K | – | 1463 |
|
|
2022
Q1 | $251K | Buy |
19,460
+2,687
| +16% | +$34.7K | ﹤0.01% | 1397 |
|
|
2021
Q4 | $268K | Buy |
16,773
+1,933
| +13% | +$30.9K | ﹤0.01% | 1325 |
|
|
2021
Q3 | $238K | Buy |
+14,840
| New | +$238K | ﹤0.01% | 1294 |
|
|
2021
Q1 | – | Sell |
-163,934
| Closed | -$2.85M | – | 1263 |
|
|
2020
Q4 | $2.85M | Buy |
+163,934
| New | +$2.85M | 0.02% | 740 |
|